skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

About Aidan

{A1EF0A44-49EE-467F-964C-F748991F5552}

+21 year(s) experience

Aidan_Fry_Pharma_Intelligence
As the co-founder of Generics bulletin, Aidan has 20 years of reporting in detail on the global generic, biosimilar, value-added and OTC medicines industries.
With over 20 years of experience of reporting on the global pharmaceutical industry, Aidan focuses in his role as editor of Generics bulletin particularly on commercial, regulatory and legal issues affecting the generic, biosimilar, value-added and OTC medicines industries. This includes in-depth analyses of corporate strategy, legislative changes, legal precedents and product perspectives. He regularly interviews leading industry executives and moderates prestigious events. Aidan also oversees the Global Generics & Biosimilars Awards. Aidan speaks fluent German and has a particular affection for maps.

Analyst Articles

Articles by Aidan